Skip to main content
Theralase Technologies Inc. (TLTFF)
OTCMKTS · Delayed Price · Currency is USD
0.1400
+0.0050 (3.70%)
Jun 18, 2025, 2:49 PM EDT

Theralase Technologies Revenue

Theralase Technologies had revenue of 91.19K CAD in the quarter ending March 31, 2025, a decrease of -48.06%. This brings the company's revenue in the last twelve months to 949.07K, down -8.63% year-over-year. In the year 2024, Theralase Technologies had annual revenue of 1.03M, down -3.45%.

Revenue (ttm)
949.07K CAD
Revenue Growth
-8.63%
P/S Ratio
53.14
Revenue / Employee
47.45K CAD
Employees
20
Market Cap
35.09M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.03M-36.88K-3.45%
Dec 31, 20231.07M-68.26K-6.00%
Dec 31, 20221.14M357.93K45.85%
Dec 31, 2021780.64K-148.48K-15.98%
Dec 31, 2020929.12K-34.93K-3.62%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Elite Pharmaceuticals 70.00M
Veradigm 588.02M
Tian'an Technology Group 1.78M
American Oncology Network 1.76B
Northwest Biotherapeutics 1.47M
Glass House Brands 215.62M
Silence Therapeutics 27.70M
Revenue Rankings

Theralase Technologies News

More News